Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Clinical trial NCT04417530 · COMPLETED

Trial details

NCT number: NCT04417530
Sponsor: Aura Biosciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Uveal Melanoma Ocular Melanoma Choroidal Melanoma

Start date: 2020-08-05
Primary completion: 2024-04-22
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.